Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
23-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Index of Authors
Author #28022
advertisement
Stalmans I
25
Showing records 1 to 25 |
Display all abstracts from
Stalmans I
106555
Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Melgarejo JD
Frontiers in cardiovascular medicine
2022; 9: 1024044
106729
The natural history of untreated ocular hypertension and glaucoma
Lauwers A
Survey of Ophthalmology
2023; 68: 388-424
105160
Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
José P
British Journal of Ophthalmology
2022; 106: 1399-1405
106729
The natural history of untreated ocular hypertension and glaucoma
Barbosa Breda J
Survey of Ophthalmology
2023; 68: 388-424
105160
Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Teixeira FJ
British Journal of Ophthalmology
2022; 106: 1399-1405
106555
Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Eijgen JV
Frontiers in cardiovascular medicine
2022; 9: 1024044
106729
The natural history of untreated ocular hypertension and glaucoma
Stalmans I
Survey of Ophthalmology
2023; 68: 388-424
105160
Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Barão R
British Journal of Ophthalmology
2022; 106: 1399-1405
106555
Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Wei D; Maestre GE
Frontiers in cardiovascular medicine
2022; 9: 1024044
105160
Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Sousa DC
British Journal of Ophthalmology
2022; 106: 1399-1405
106555
Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Al-Aswad LA
Frontiers in cardiovascular medicine
2022; 9: 1024044
105160
Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Marques RE; Barata ADO
British Journal of Ophthalmology
2022; 106: 1399-1405
106555
Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Liao CT
Frontiers in cardiovascular medicine
2022; 9: 1024044
105160
Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Marques-Neves C
British Journal of Ophthalmology
2022; 106: 1399-1405
106555
Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Mena LJ
Frontiers in cardiovascular medicine
2022; 9: 1024044
105160
Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Alves M
British Journal of Ophthalmology
2022; 106: 1399-1405
106555
Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Vanassche T
Frontiers in cardiovascular medicine
2022; 9: 1024044
105160
Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Papoila AL
British Journal of Ophthalmology
2022; 106: 1399-1405
106555
Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Janssens S
Frontiers in cardiovascular medicine
2022; 9: 1024044
105160
Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Stalmans I
British Journal of Ophthalmology
2022; 106: 1399-1405
106555
Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Verhamme P; Keer KV
Frontiers in cardiovascular medicine
2022; 9: 1024044
105160
Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Silva JP
British Journal of Ophthalmology
2022; 106: 1399-1405
106555
Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Stalmans I
Frontiers in cardiovascular medicine
2022; 9: 1024044
105160
Trabeculectomy with mitomycin C alone or coupled with intracamerular bevacizumab? A 2-year comparative study
Abegão Pinto L
British Journal of Ophthalmology
2022; 106: 1399-1405
106555
Progression of functional and structural glaucomatous damage in relation to diurnal and nocturnal dips in mean arterial pressure
Zhang ZY
Frontiers in cardiovascular medicine
2022; 9: 1024044
Issue
23-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement